Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
OTC PK
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.30K | 4.00K | 1.30K | 7.00K | 5.90K |
| Total Receivables | 7.80K | 14.20K | 12.40K | 9.60K | 8.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.30K | 32.40K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 54.50K | 50.60K | 13.70K | 16.50K | 14.80K |
|
|
|||||
| Total Current Assets | 54.50K | 50.60K | 13.70K | 16.50K | 14.80K |
| Net Property, Plant & Equipment | 2.00K | 4.10K | 6.30K | 5.20K | 8.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.20K | 30.00K | 26.50K | 22.70K | 50.50K |
| Total Assets | 70.70K | 84.80K | 46.40K | 44.40K | 73.40K |
|
|
|||||
| Total Accounts Payable | 486.20K | 427.10K | 380.20K | 364.90K | 373.70K |
| Total Accrued Expenses | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| Short-term Debt | 299.10K | 51.90K | 51.90K | 51.90K | 226.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 218.20K | 211.00K | 189.20K | -- |
| Total Other Current Liabilities | -- | 218.20K | 211.00K | 189.20K | -- |
| Total Current Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
|
|
|||||
| Total Current Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 299.10K | 51.90K | 51.90K | 51.90K | 226.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
|
|
|||||
| Common Stock & APIC | 8.02M | 8.02M | 8.02M | 8.02M | 8.02M |
| Retained Earnings | -8.89M | -8.78M | -8.77M | -8.73M | -8.70M |
| Treasury Stock & Other | -2.00K | -2.00K | -2.00K | -2.00K | -2.00K |
| Total Common Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
|
|
|||||